Evidence map›Paper›PMID 30903256›Full record

ArticleInternational orthopaedics2019

Comorbidity and mortality after hip fracture in nineteen thousand six hundred and eighty two patients aged eighteen to sixty five years in Denmark from 1996 to 2012.

Adam Omari, Christian Medom Madsen, Jes Bruun Lauritzen, Henrik Løvendahl Jørgensen, Fie Juhl Vojdeman

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Article
  6. Mortality-Related Risk Factors in Geriatric Patients with Hip Fracture.Annals of geriatric medicine and research · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adam OmariFaculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.
Christian Medom MadsenDepartment of Clinical Biochemistry, Herlev & Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Jes Bruun LauritzenDepartment of Orthopedic Surgery, Bispebjerg Frederiksberg Hospital, Copenhagen, Denmark.
Henrik Løvendahl JørgensenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Fie Juhl VojdemanDepartment of Clinical Biochemistry, Bispebjerg Frederiksberg Hospital, Copenhagen, Denmark. fie.juhl.vojdeman@regionh.dk.ORCID 0000-0001-5032-5004

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis nationwide study assessed associations between comorbidity and mortality after hip fracture in young and middle-aged patients.

methodsData on 19,682 patients aged 18 to 65 years were extracted from Danish registries out of 154,047 patients who experienced a hip fracture between 1996 and 2012. Mortality and comorbidity were assessed using information on vital status, hospital admissions, and prescriptions.

resultsOf the 19,682 patients 17,722 (90.0%) were middle-aged (40-65 years) and 1960 (10.0%) were young (18-39 years). The 30-day mortality rates were 3.2% (n = 570) and 1.6% (n = 32), respectively. Indicators of multi-trauma (hazard ratio (HR), 3.5 95% confidence interval (CI) [1.6-7.8], n = 2056) and having diabetes (HR, 4.4 [1.2-11.3], n = 59) and heart disease (HR, 4.4[1.3-14.8], n = 57) increased 30-day mortality in the young patients, while having cancer (HR, 5.0 [4.2-5.9], n = 1958) increased 30-day mortality in the middle-aged patients.

conclusionHeart disease and diabetes were associated with high mortality in the young patients while having cancer was associated with high mortality in the middle-aged patients.

Indexed as

AdolescentAdultAgedAge FactorsComorbidityDenmarkDiabetes MellitusFemaleHeart DiseasesHip FracturesHumansMaleMiddle AgedNeoplasmsRegistriesYoung AdultAgeComorbidityDiabetesHeart diseaseHip fracture

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.